TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›ICU›Financials
Annual statements · SEC XBRL · FY2020 – FY2025

SeaStar Medical Holding Corp (ICU) financials

Income statement

SeaStar Medical Holding Corp (ICU) income statement, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Revenue———$0.00$135K$1.23M
Revenue growth—————814.1%
Gross profit———$0.00$135K$1.18M
Gross margin————100.0%95.7%
Operating income—-$4.45M-$11.6M-$14.2M-$17.8M-$12.2M
Operating margin————-13216.3%-986.6%
Net income—-$4.60M-$12.2M-$26.2M-$24.8M-$12.2M
Net margin————-18392.6%-984.6%
EPS (diluted)—-$0.63-$1.48-$30.26-$6.63—

Cash flow

SeaStar Medical Holding Corp (ICU) cash flow, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow—-$5.11M-$7.79M-$10.3M-$16.0M-$13.6M

Balance sheet

SeaStar Medical Holding Corp (ICU) balance sheet, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$2.81M$510K$47.0K$176K$1.82M—
Total assets$269K$603K$3.04M$3.51M$4.66M$14.2M
Total liabilities$249K$3.42M$23.8M$17.4M$6.84M$3.74M
Long-term debt——$7.65M$4.14M——
Shareholders' equity$1.77M-$2.82M-$20.8M-$13.9M-$2.18M$10.4M
Retained earnings-$5.24K-$76.3M-$88.5M-$115M-$140M-$152M
Shares (wtd avg diluted)—7.24M8.21M867K374K2.07M

Every figure is extracted from SeaStar Medical Holding Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is SeaStar Medical Holding Corp's annual revenue?
SeaStar Medical Holding Corp (ICU) reported $1.23M of revenue for fiscal year 2025 — up 814.1% from $135K in FY2024, per its annual report filed with the SEC.
Is SeaStar Medical Holding Corp profitable?
Not in FY2025 — ICU reported a net loss of $12.2M, per SEC filings.
Does ICU pay a dividend?
SeaStar Medical Holding Corp reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full ICU analysis — verdict, score & filings →Is ICU a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.